Track 1: Globalized Pharma Sector

Globalized Pharma Sector is based on gaining information on  changing structure of competition and increased competitiveness,  lack of brand new products,  despite increased investments into R&D (Research& Development) activities,  increased importance of regulatory issues (registrations, intellectual property rights, litigations),  fast consolidation and concentration of the world  Pharmaceutical industry can be known as the Globalized Pharma Sector.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU)

Track 2: Drug Discovery

In the fields of medicine, biotechnology and Pharmacology, drug discovery is the process by which new candidate medications are discovered. Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity,  selectivity (to reduce the potential of side effects),  efficacy or potency,  metabolic stability  (to increase the half-life),  and oral bioavailability.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU)

Track 3: Drug Development

Drug development focusses on launch of new Pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED.

Track 4: Pharmaceutical Engineering

Pharmaceutical engineering deals with Pharmaceutical Science and technology that involves development and manufacturing of products, processes, and components in the Pharmaceuticals industry (i.e. drugs & biologics). While developing Pharmaceutical products involves many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers, biomedical engineers, etc.), the specific subfield of "Pharmaceutical engineering" has only emerged recently as a distinct engineering discipline.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 5: Advances in Pharmaceutical Packaging

Packaging plays an important role in providing protection, presentation, convenience, identification information, and compliance of a product during storage, transportation, display and until the product is safely consumed. Packaging may be considered as a system by which the product safely reaches from producer to consumer. The track mainly focuses on recent advances in packaging technology and packaging material. Many types of symbols for package labeling should be nationally and internationally standardized. Packaging symbols represent product certifications, trademarks, proof of purchase.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED.

Track 6: Purpose and Principles of GMP

Good Manufacturing Practices quality of drugs is essentially the responsibility of manufacturers. GMP Guidelines are means to assure this very quality of drugs. CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the CGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. GMP is actually good common sense quality management quality assurance GMP production and quality control.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), European Association of Employed Community Pharmacists in Europe (EPhEU), Pharmaceutical Group of the European Union (PGEU).

Track 7: Pharmaceutical Supply Chain Optimization

Supply chain management (SCM) is the integration of key business processes across the supply chain for the purpose of creating value for customers and stakeholders. Indeed supply chain management integrates supply and demand within and across companies in an efficient business model. The Council of Supply Chain Management Professionals defines supply chain management as planning and management of all activities involved in sourcing, procurement, conversion and all logistics activities. There are various aspects of optimizing in the supply chain; eliminating bottlenecks, balancing between lowest material cost and transportation, optimizing manufacturing flow, maintaining the right mix and location of factories and warehouses, vehicle routing analysis, dynamic programming and efficient use of capacities, inventories, and labours are of main aspects of supply chain optimization.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 8: Pharmaceutical Process Validation

Pharmaceutical Process Validation is the most important and recognized parameters of CGMPs. Quality cannot be adequately assured by in-process and finished inspections and testing but it should be built in to the manufacturing process. These processes should be controlled in order that the finished product meets all quality specifications. Validation is one of the important steps in achieving and maintaining the quality of the final product. The requirement of process validation appears of the quality system (QS) regulation. The goal of a quality system is to consistently produce products that are fit for their intended use.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED.

Track 9: Regulatory Requirements for Pharmaceuticals

The area unit variety of motives for extending the merchandise development outside of the mature, developed economies (e.g. the EU and therefore the US) and most of them have faith in the high population and market potential of rising markets. FDA guidance for clinical investigations and Pharmaceutical development goes a lot of and a lot of international within the direction of rising markets that tend to supply solutions for the patient achievement and overall development prices and timelines.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 10: Medico Marketing

Medico-Marketing focusses on exchange of drug information among drug manufacturing company and the recommending doctor, Nurse, Pharmacist or with the end user. The intention behind this data exchange is to describe the Pharmaceutical Company’s products and how it will benefit the patient community in diagnosis or management of the human ailments.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED.

Track 11: Generics versus Big Pharma

Yet over the past decade in particular, most of the Big Pharmas have adopted small molecule generics in one shape or form into their overall business model. And many of them openly talk about the “innovation headroom” that a healthy low-priced generics market enables i.e. the money saved on off-patent drugs can be used to fund high-priced new innovations. They have recognized that they cannot fight the realities of aging populations and healthcare economics.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), European Association of Employed Community Pharmacists in Europe (EPhEU), Pharmaceutical Group of the European Union (PGEU).

Track 12: Pharma and Biotech Financial Outlook

The downturn in the global economy has forced Pharmaceutical and life sciences companies to focus on cost-saving initiatives, putting stress on finance departments. Although optimizing costs will always be important, reinvigorating R&D will most likely be a top strategic initiative for these companies as well. Most big Pharmaceutical companies are under competitive pressure from generic drug makers pressure that will become more intense as an increasing number of patents for “blockbuster” drugs expire during the next few years.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 13: Digital Pharma

Some of the people believes that digital capabilities are not only critical to Pharmaceutical companies’ ability to improve the way they roll out new products, but to increasing the Pharmaceutical industry’s contribution to health care by enabling it to provide innovative services to improve patients’ outcomes. In order to increase the perceived value of Pharma within the health care system, the industry is striving to respond to the needs of all stakeholders: health care professionals, patients and payors. In the meantime, the culture of Pharmaceutical companies is shifting from one of separate departments working vertically to one that is crossfunctional.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 14: R&D Advancement: Road to New Medicines

Big pharmaceutical companies develop new business models to cope with the innovation crisis (patent loss, drying up of pipelines) and to improve their productivity in R&D and innovation. These pressures led big players to transform or reinvent their business models to sustain value creation from R&D and innovation. However, to our knowledge, there is still a lack of understanding regarding the “strategic alignment” of these organizational changes and on how they are perceived by organizational members.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED.

Track 15: Clinical Pharmacy and Therapeutics

Drug absorption is set by the drug’s chemistry properties, formulation, and route of administration. Dosage forms (e.g. tablets, capsules, solutions), consisting of the drug and alternative ingredients, square measure developed to lean by numerous routes (e.g. oral, buccal, sublingual, rectal, parenteral, topical, inhalational). In spite of the route of administration, medicine should be in answer to be absorbed.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 16: Pharmaceutical Sciences

The pharmaceutical sciences combine broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies. Pharmaceutical Sciences is a dynamic and interdisciplinary field that aims to integrate fundamental principles of physical and organic chemistry, engineering, biochemistry, and biology to understand how to optimize delivery of drugs to the body and translate this integrated understanding into new and improved therapies against human disease. At the many of institutes internationally recognized faculty contribute to the field through inquiry into the underlying mechanisms of drug interactions with the human body and development of advanced synthetic or biologically-derived materials that can modulate these interactions in pursuit of better and safer therapies and drug products.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED.

Track 17: Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signaling and activity. Pharmaceutical nanotechnology embraces  applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), European Association of Employed Community Pharmacists in Europe (EPhEU), Pharmaceutical Group of the European Union (PGEU).

Track 18: Entrepreneurs Investment Meet

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment.

Related Pharma Conferences: Pharmaceutical Conferences | Pharma Conferences 2020 | Pharmaceutics Meetings | Pharmaceutical Sciences Conferences | Pharma Industry 2020 Conferences | Dubai Pharma Expo 2020 | Biopharma Conferences | Pharmaceutical Conferences 2020 USA | Novel Drug Delivery Conferences | Pharmacology Conferences | Nanomedicine Conferences

13^th Pharmacovigilance and Drug Safety Conference, July 27-28, 2020 Zurich, Switzerland; 11^th World Congress on Bioavailability and Bioequivalence March 11-12, 2020 Dubai, UAE; 23^rd Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 22^nd Toxicology and Applied Pharmacology, July 15-16, 2020 Vienna, Austria.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), European Association of Employed Community Pharmacists in Europe (EPhEU), Pharmaceutical Group of the European Union (PGEU).

Market Research on Pharmaceutical Sciences

The Board of Pharmaceutical Sciences (BPS) of the International Pharmaceutical Federation (FIP) has developed a view on the future of pharmaceutical sciences in 2020. The global pharmaceutical market is projected to reach 10.27 billion USD by 2025. The market is expected to see a growth at 13.1% CAGR owing to increasing incidence of Adverse Drug Reaction. The key driver for the growth of the pharmaceutical market is ADR’s. In 2015, the U.S. FDA received almost 253,017 serious adverse events and 44,693 deaths associated with adverse drug reactions (ADRs). This shows the possible demand for instigating safety and pharma services. The statistic shows the projected growth of the world pharmaceutical market by the regional group between 2018 and 2022. It is expected that the pharmaceutical market will have a compound annual growth rate of 6 to 9 percent in this period.

This statistic describes the projected global pharmaceutical market growth for the period 2016-2021, measured by the compound annual growth rate (CAGR) and sorted by regional submarkets. It is expected that North America will grow at a CAGR of 4.3 percent.

The global market for natural & plant-derived drugs was valued at $23.2 billion in 2013 and $24.4 billion in 2014. This total market is expected to reach $35.4 billion in 2020, with a Compound Annual Growth Rate (CAGR) of 6.6% from 2015 to 2020.

Pharmaceuticals represented a US$300 bn-a-year market globally as of 2015, the World Health Organization states. The global pharmaceutical market is expected to surpass US$400 bn by 2018. Worldwide prescription drug sales forecasted to grow at a robust 6.5% (CAGR) through 2022 to reach $1.06trn. 32% of the 2022 increase in sales to come from orphan drugs (+$95bn).

Major Pharma Associations around the Globe:

• Academy of Managed Care Pharmacy (AMCP), Alexandria, VA
• American Association of Pakistani Pharmaceutical Scientists
• British Columbia Pharmacy Association
• California Pharmacists Association
• Kansas Pharmacists Association
• Ohio Pharmacists Association
• Pharmacy Guild of Australia
• European Association of Pharma Biotechnology
• Pharmaceutical Group of the European Union
• European Federation of Pharmaceutical Industries and Associations
• European Biopharmaceutical Enterprises
• European Federation of Pharmaceutical Industries and Associations
• European Biotechnology
• Farmaindustria
• European Pharmaceutical Union (EPU)
• Pharmaceutical Group of the European Union (PGEU)
• European Association of Employed Community Pharmacists in Europe (EPhEU)
• Danish Association of Pharmaconomists
• Norwegian Pharmacy Association

The Pharmaceutical Industry: A Key Asset to The European Economy

As driving medical progress by researching, developing and bringing new medicines that improve health and quality of life for patients around the world, the research-based pharmaceutical industry is a key asset of the European economy. It is one of Europe’s top performing high technology sectors.

PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE

 All new medicines introduced into the market are the result of lengthy, costly and risky research and development (R&D) conducted by pharmaceutical companies: Certain key factors that decide the market value of a pharmaceutical product are:

â–  by the time a medicinal product reaches the market, an average of 12-13 years will have elapsed since the first synthesis of the new active substance;

â–  The cost of researching and developing a new chemical or biological entity was estimated at € 1,172 million ($ 1,506 million in year 2011 dollars) in 2012 (Mestre-ferrandiz et al, office of Health Economics, December 2012);

â–  on average, only one to two of every 10,000 substances synthesised in laboratories will successfully pass all stages of development required to become a marketable medicine.

Hence the value of the product is set accordingly keeping in mind all such factors.

The value of pharmaceutical research based on the amount of research funding in different countries in Europe can be compared from the table below

EfpIA 2012 € million
Austria	453
Belgium	2,343
Bulgaria	n.a.
Croatia	40
Cyprus	14
Czech  Republic	49
Denmark	1,411
Estonia	n.a.
Finland	264
France	4,392
Germany	5,767
Greece	84
Hungary	158
Ireland	194
Italy	1,230
Latvia	n.a.
Lithuania	n.a.
Malta	n.a.
Netherlands	642
Norway	141
Poland	227
Portugal	88
Romania	200
Serbia	n.a.
Slovakia	n.a.
Slovenia	164
Spain	997
Sweden	942
Switzerland	4,965
Turkey	83
United Kingdom	5,187
Total	30,035

IMPORTANCE OF PHARMACEUTICAL R&D

In 2012 the pharmaceutical industry invested more than € 30,000 million in R&D in Europe. A decade of strong uS market dominance led to a shift of economic and research activity towards the uS from 1995-2005. Additionally, Europe is now facing increasing competition from emerging economies: rapid growth in the market and research environments in countries such as brazil and china are contributing to the move of economic and research activities to non-European markets. The geographical balance of the pharmaceutical market – and ultimately the R&D base – is likely to shift gradually towards emerging economies

Pharmaceutical R&D Expenditure - Annual Growth Rate %

PHARMACEUTICAL SALES

The world pharmaceutical market was worth an estimated € 655,222 million ($ 870,200 million) at ex-factory prices in 2013. The north american market (usa&canada) remained the world’s largest market with a 41.0% share, well ahead of europe and japan.

Breakdown of the World Pharmaceutical Market – 2013 Sales

PRICE STRUCTURE

Distribution margins, which are generally fixed by governments, and vat rates differ significantly from country to country in Europe. On average, approximately 34% of the retail price of a medicine reverts not to the manufacturer, but rather to the distributors (pharmacists and wholesalers) and the state.

Breakdown of the Retail Price Of A Medicine, 2012 (%)

The pharmaceutical industry comprises of companies that are engaged in research, development, manufacture and distribution drugs for human or veterinary use. The primary function of the research-based pharmaceutical corporations is to create value by discovering and producing effective medicines, vaccines and services that improve patients’ well-being, and can be sold in markets at a profit. As well as increasing shareholder value, this contributes significantly to the quality and protection of life and helps make the world a better place. In the past 60 years, innovation and technology have driven huge improvements in global health.

The pharmaceutical industry is undergoing a tremendous deal of change. There are many pharmaceutical companies, who are providing the better products. The Pharma industry is one of the most sought after, and flourished industries. As the pharmaceutical drug manufacturers are one of the reasons for the economic well being of a nation. On the other hand, we can say that the Pharma industry is responsible for the economic development. That is the main reason for both research and development of newer and better products for various kinds of diseases.

Top Pharma companies around the Globe:

• Johnson & Johnson
• Novartis
• Roche
• Pfizer
• GSK (GlaxoSmithKline)
• AstraZeneca
• Gilead Sciences

As a highly specialized production location for pharmaceutical products, Switzerland enjoys an excellent reputation the world over. The presence of highly qualified scientists and pharmaceutical talent from the world’s leading universities make a significant contribution towards developing new medicines. The framework conditions are also in place: the Swiss healthcare system supports the introduction of new medicines and, in doing so, offers companies access to a sophisticated test and sales market. In addition to Switzerland, international markets play a decisive role. Value added in the pharmaceutical industry has continued to increase over the last decade in Switzerland. Switzerland is by far the most important stock exchange for Life Sciences companies in Europe.

Global Pharmaceutical Industry 2013-2018: Trend, Profit, and Forecast Analysis

The global pharmaceutical industry revenue is forecasted to reach an estimated $1,226.0 billion by 2018, with good growth over the next five years (2013-2018). The industry is expected to register growth led by aging population, changing lifestyles, hectic daily activities, unhealthy eating habits, increasing incidence of chronic diseases across the entire global population providing growth opportunities for the industry players.

The industry is engaged in discovery, development, manufacture, and marketing of prescription drugs. Industry products include ethical drugs and consumer healthcare but animal healthcare drugs are not included.
The global pharmaceutical market faces major challenge from increasing investment and strict regulation. Changing lifestyles and the fast socio-demographic shift due to urbanization in both developed and growth markets globally are expected drive the demand. The ability to create new technology and innovative drugs is a key driver for success in this market. 
North America is projected to lead the pharmaceutical industry. Vaccine industry is expected to record the highest growth during the forecast period. ROW industry is expected to witness the highest growth during 2013-2018. Government initiatives in Brazil to encourage drugs industries by providing free pricing policies and special financial investment options will attract the industry players. APAC holds good growth potential for the future.
This study provides an overview of the global pharmaceutical industry by tracking 13 market segments of that industry in four geographic regions. Thus, a total of 52 segments of the global pharmaceutical industry are tracked. The report studies manufacturers of bone, respiratory, immunology and dermatology, cardiovascular, diabetes & obesity, urinary/kidney diseases, gastrointestinal, neurosciences, infectious diseases, ophthalmology, oncology, women’s health/ endocrine, vaccines, consumer health/OTC, and others providing a five-year (2007-2012) annual trend analysis that highlights market size, profit and cost structure for NA, Europe, APAC, and ROW. The report also provides a forecast, addressing market opportunities for next five years (2013-2018) for each of these regions. 

This comprehensive guide provides readers with valuable information and the tools needed to successfully drive critical business decisions with a thorough understanding of the market’s potential. This report will save clients hundreds of hours in personal research time on a global market and it offers significant benefits in expanding business opportunities throughout the global pharmaceutical industry analysis. In a fast-paced ever-changing world, business leaders need every advantage available to them in a timely manner to drive change in the market and to stay ahead of their competition. This report provides business leaders with a keen advantage in this regard by making them aware of emerging trends and demand requirements on an annual basis. 

Features and Scope of this Report:

To make any investment or strategic decision, you need adequate and timely information. This market report fulfils this core need. Some of the features of this market report are:

- Industry size estimates in terms of (US $) value by regions and by segments
- Global pharmaceutical industry annual trend (2007-2012) and forecast (2013-2018)
- Porter’s Five Force analysis
- New product launch, merger and acquisition activity in global pharmaceutical industry
- Quarterly demand trend (Q1 2011-Q4 2012) and forecast analysis (Q1 2013-Q4 2014) for pharmaceutical industry analysis
- Gross and net profit trends in the global pharmaceutical industry
- Cost structure trend in the global as well as regional pharmaceutical industry

Market Analysis of Global Pharmaceutical Industries:

The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015, but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year, and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022, and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.

The global market for drug discovery technologies and products was worth $38.4 billion in 2011. This figure is projected to reach $41.4 billion in 2012 and $79 billion in 2017, a five-year compound annual growth rate (CAGR) of 13.8%. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

The fast-growing division of the pharmaceutical market includes generics and biologics. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval.15 U.S generic drug sales reached an estimated $70 billion, representing a quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favoring generics. Although generics make up only 22 percent of total prescription sales, its share of filled prescriptions has risen from 19 percent in 1984 to 88 percent in 2015. The research-based pharmaceutical industry is estimated to have spent nearly USD 149.8 billion globally on pharmaceutical R&D in 2015-16. Among all the industrial sectors, the research-based pharmaceutical industry has consistently invested the most in research and development, even in times of economic turmoil and monetary crisis.

According to the Quintiles IMS Institute predicts that the pharmaceutical market by 2021 will reach nearly USD 1,485 billion, by an increase of USD 350-380 billion from the USD 1,105 billion recorded in 2016. Global brand spending is forecast to increase to USD 815-832 billion in 2021. Global generic spending is expected to increase to USD 495-505 billion by 2021.

The United States share of global spending will increase from USD 461.7 billion in 2016 to USD 645-675 billion in 2021, while the European share of spending will grow from USD 151.8 billion to USD 170-200 billion. Meanwhile, pharmerging countries will spend nearly 315-345 USD billion in 2021 from 242.9 in 2016.

Glance at Market of Pharma:

These data describe the outcome of the patient as defined in U.S reporting regulations. Serious means that one or more of the following outcomes were documented in the report: death, hospitalization, life threatening. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacy.

The Changing Geography of Pharma Markets

Growth over past decades means that North America and Western Europe still account for 56% of the global market, but Asia Pacific has overtaken Western Europe as the second largest region. Growth in Asia Pacific is fueled by increased affordability of drugs resulting from the launch of low-priced generics. Other factors that are positive for growth in Asia Pacific are the rise of GDP per capita in the region, government programs to support healthcare, and rapid urbanization, which brings both doctors and pharmacies within easy reach of increasing proportions of growing populations. Pharma sales in Asia Pacific will grow at 8.4% a year to 2021.

The story is a similar one at the level of country. The USA, by itself worth 25% of the global total, is restraining global growth by rising at below 5% a year, while the much smaller pharma markets of India and China are both achieving double that pace.

Key Segments in the Pharmaceutical Market

The largest pharma market globally is for musculoskeletal drugs. These are treatments for diseases such as rheumatoid- and osteo- arthritis, osteoporosis, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others. Major drugs in this segment include Piroxicam Glaxo, Dolonex, Felden, and Piroxicam Pfizer. The segment accounted for 14% of the global total in 2017. Cardiovascular, oncology and ant-infective drugs are the second third and fourth largest markets.

Drugs for treating metabolic disorders such as diabetes and diseases of the thyroid and pituitary glands will be the fastest-growing segment of the global pharma market to 2021. This segment will grow at 9% a year going forward, following recent growth of 11.6%, but it will remain in fifth place for market size.

Pharmaceutical Journals

Journal of Pharmaceutical Sciences | International Journal of Pharmaceutics | The Pharmaceutical Journal | Pharmaceutical Research | European Journal of Pharmaceutics and Biopharmaceutics | Molecular Pharmaceutics | European Journal of Pharmaceutical Sciences | Asian Journal of Pharmaceutics | Journal of Pharmacy and Pharmacology  | Indian Journal of Pharmaceutical Sciences | Journal of Pharmacy and Pharmaceutical Sciences | Drug Development and Industrial Pharmacy | Journal of Pharmacy Practice | American Journal of Pharmaceutical Education | International Journal of Drug Development & Research | Journal of Bioequivalence & Bioavailability | Journal of Bioanalysis & Biomedicine | Journal of Pharmacogenomics & Pharmacoproteomics | Journal of Vaccines & Vaccination | Journal of Drug Metabolism & Toxicology | Drug Designing: Open Access | Medicinal & Aromatic Plants | Journal of Biomolecular Research & Therapeutics | Research & Reviews in Pharmacy and Pharmaceutical Sciences | Journal of Molecular Pharmaceutics & Organic Process Research | Journal of Developing Drugs | Journal of Pharmaceutics & Drug Delivery Research | Molecular Enzymology and Drug Targets | Research & Reviews: Journal of Pharmaceutics and Nanotechnology | Journal of Pharmacokinetics & Experimental Therapeutics

Top Pharmaceutical Universities around the world:

Harvard University | University of Cambridge | University of California, San Francisco | University College London | University of North Carolina | Karolinska Institute | Yale University | King's College London | University of California, San Diego | Cardiff University | Stanford University | The Imperial College of Science, Technology and Medicine | The University of Manchester | The University of Texas | Utrecht University | The University of Dundee | Columbia University | Monash University | University of Oxford | Pierre and Marie Curie University | Medical University of Vienna | Rockefeller University | Uppsala University | University of Pennsylvania | University of Zurich | University of Tuebingen | The Ohio State University | Radboud University Nijmegen| Norwegian University of Science and Technology | Vanderbilt University | McGill University | University of Hamburg | University of Lausanne | University of Paris Descartes  | The University of Tokyo | University of California, Berkeley | Swiss Federal Institute of Technology Zurich | Kyoto University | University of Wisconsin – Madison | University of Arizona | University of South Florida | University of Utah | China Pharmaceutical University

Asia Pharmaceutical Universities

University of Tokyo | National University of Singapore | Kyoto University | University of Hong Kong | Peking University | Seoul National University | National Taiwan University  | Osaka University | Tsinghua University | Chinese University of Hong Kong | Fudan University |The Hong Kong University of Science and Technology | Taipei Medical University | Mahidol University | Korea Advanced Institute of Science and Technology | Yonsei University |Shanghai Jiao Tong University | Nanyang Technological University | Chulalongkorn University | Tohoku University | Tokyo Medical and Dental University | Kyushu University |Nagoya University | Hokkaido University | Sungkyunkwan University | University of Science and Technology of China | Pohang University of Science and Technology | Korea University | University Malaya  | Indian Institute of Science

Europe Pharmaceutical Companies

Mylan | Astellas Pharma | Novo Nordisk | Boehringer Ingelheim | Allergan | Takeda | Bristol-Myers Squibb | Eli Lilly | Teva Pharmaceutical Industries | Amgen | AbbVie | AstraZeneca | GlaxoSmithKline | Gilead Sciences | Merck | Sanofi | Roche | Pfizer |  Novartis | Bayer | Johnson and Johnson | QPS | Biocrates | ThioMatrix | Polymun Scientific | Croma-Pharma | Affiris | Aposcience | EverCyte| Octapharma | Teleflex Medical | Janssen Pharmaceuticals | Lonza | Bone Therapeutics | Formac Pharmaceuticals | Oncurious | Sanofi Genzyme | Alexion | Baxter | Chemnovatic | CSL Behring | Custom Pharmaceuticals | Fujirebio Europe | Galen Limited | Martindale Pharma | Novo Nordisk A/S  | Petrone Group | Purna Pharmaceuticals  | Shire | UCB Pharma | Uni-Pharma | Covidien | Fresenius Se | Fresenius Medical | Rhoen Klinikum | Morphosys | Stada Arzneim | Carl Zeiss Meditec | Freudenberg medical | Emergent biosolutions | Aran biomedical | Norgine | Lexogen | Haplogen | Octimet Oncology | Anacura | Ablynx | Novasep | Flen Pharma | Toxikon |  Zoetis | Pharmavize | Galapagos | Eurogentec | LinaTech | Stada | Synthon | Ferring Pharmaceuticals | Lonza | UBC | Leo Pharma | Saniona | DanDrit Biotechnology | Taconic Biosciences | West Pharma

Asia  Pharmaceutical Companies

3-D Matrix | Agilent | BeiGene | BioDuro | China Biological Products | Fosun Pharma | Lumenis| MicroPort | Senju Pharmaceutical | Sihuan Pharmaceutical | Sinovac Biotech | DesigneRx Pharmaceuticals | Pharmadax | Denovo Biopharma | BioMarin Pharmaceuticals | Invitrogen | WuXi Apptec | AngioDynamics | SciGenom | Dishman Specialty Chemicals | Intas Pharmaceuticals | Zydus Cadila | Advinus Therapeutics | Sigma-Aldrich | Par Pharmaceutical | Gland Pharma | Natco Pharma | Haffkine Biopharmaceuticals | Allergan | Taisho Pharmaceutical | Dainippon Sumitomo | Wakunaga Pharmaceutical | Dainippon Sumitomo | Santen | Chugai Pharma| Kissei Pharmaceutical | WaVe Life Sciences | Mitsubishi Tanabe Pharma | Astellas | Daiichi Sankyo | AnGes | Kubota Pharmaceutical | Ohara Pharmaceutical | Daewon Pharma | Charles River Laboratories | Oxonc Development | Yungjin Pharmaceutical | Neopeutics | Austrianova Biotechnology | 3M | Clinuvel Pharmaceuticals | Micropoint Technologies | Sphaera Pharma | VolitionRx | China Chemical and Pharmaceutical Company| Foresee Pharmaceuticals

African Pharmaceutical Companies

Fresenius Kabi Distribution | Luced Agencies | Akacia Health | Roche Pharmaceuticals | Biotech Laboratories  | Allied Drug Company | Janssen-cilag | Teva Pharmaceuticals | Medimoc Sarl | Bayer International Service | Boehringer Ingelheim | Columbia Pharmaceuticals | Ultimate Sport Nutrition | Astra Zeneca Pharmaceuticals | Resmed Pharmaceuticals | Servier Laboratories | Embassy Pharmaceuticals | Amalgamated Pharmaceuticals | New S Buys | Afrox Limited | Amka Pharmaceuticals | Astra Pharmaceuticals | Brunel Laboratoria | Dia-Kure Ltd | Eden Pharmaceuticals Prod | Geo Schwulst Laboratories | GM Pharmaceuticals | Hersol Manufacturing Laboratories | Intramed | Johnson & Johnson | Kyron Laboratories | Merck Generics RSA | Novo Nordisk | Pharma Natura | Pharmacare Ltd | Resmed Pharmaceuticals | S N Pharmaceuticals | Smith & Nephew Pharmaceuticals | Smithkline Beecham

Pharmaceutical Jobs

Research Associate & Research Scientist - FR&D in Trikona Pharmaceuticals Private Limited | Pharmacist - Pentagon Global Solutions Limited | QA/QC in MSN Laboratories | Sr. Executive/asst. Manager/manager-Pharma Techni in Arihant Innochem Pvt Ltd | Sr. Executive / Exe IPR Formulation- Leading Pharma in Harman Finochem Ltd | Apotex- Analytical R&D Opportunity | Junior Research Fellow in South India Textile Research Association | Research & Development (F&D) in Zim Laboratories Limited | Sr Research Associate Formulations R&D in Celon Laboratories Ltd | Sr. Officer F & D (Pharmaceutics) in SMVA Consultants | Manager in Torrel Cos. Pvt. Ltd | Quality Assurance in Suven Life Sciences Ltd | Risk Management Plan  Manager in Novartis | Associate Global Trial Director in Novartis  | Product Manager - Ophthalmology | Cardio-Diabetes for Pharma company  | Brand Manager / Product Executive in Senses pharmaceuticals ltd | Stores Clerk in Aristo Pharmaceuticals Pvt. Ltd. | Area Sales Manager in East West Pharma (Pvt) Ltd

Associations and Societies:

Academy of Managed Care Pharmacy (AMCP)

Accreditation Council for Pharmacy Education

Alabama Board of Pharmacy

American Association of Colleges of Pharmacy (AACP)

American Association of Pakistani Pharmaceutical Scientists

American Association of Pharmaceutical Scientists (AAPS)

American Association of Pharmacy Technicians (AAPT)

American College of Clinical Pharmacology

American College of Clinical Pharmacy (ACCP)

American Institute of the History of Pharmacy

American Pharmacists Association (APhA)

American Society for Clinical Pharmacology and Therapeutics

American Society of Consultant Pharmacists (ASCP)

American Society of Health-System Pharmacists

American Society of Pharmacognosy

Arkansas State Board of Pharmacy

Association of Pharmacy Technicians UK

Austrian Association of Hospital Pharmacists

Austrian Pharmaceutical Society

Board of Pharmaceutical Specialties

British Columbia Pharmacy Association

British Pharmaceutical Nutrition Group

California Pharmacists Association

Canadian Pharmacists Association (CPhA)

Canadian Society for Pharmaceutical Sciences

Canadian Society of Hospital Pharmacists

Commission for Certification in Geriatric Pharmacy

Deutsche Gesellschaft fur Geschichte der Pharmazie

Drug Information Association

Federation of Pharmacy Networks

Georgia Pharmacy Association

Guild of Healthcare Pharmacists

IAGIM

Illinois Council of Health-System Pharmacists

Illinois Pharmacists Association

Indian Pharmaceutical Association

Indiana State Board of Pharmacy

Institute for Safe Medication Practices

Institute of Pharmacy Management International Ltd

International Academy of Compounding Pharmacists

International Pharmaceutical Federation (FIP)

International Pharmaceutical Students' Federation

International Society for Pharmaceutical Engineering

International Society for Pharmacoepidemiology

Kansas Pharmacists Association

Kuwait Pharmaceutical Association

International Professional Pharmacy Fraternity

Maharashtra State Pharmacy Council

Maine Society of Heath-System Pharmacists

Malaysian Pharmaceutical Society

Maryland Pharmacists Association - MPhA

Muslim Pharmacists Association (M.P.A.)

National Association of Boards of Pharmacy (NABP)

National Association of Chain Drug Stores

National Association of Pharmacy Regulatory Authorities

National Community Pharmacists Association

National Council for Prescription Drug Programs

National Independent Pharmacy Coalition

National Pharmaceutical Association

National Pharmacy Purchasing Association

National Pharmacy Technician Association

New Mexico Society of Health-System Pharmacists

New York State Council of Health-Systems Pharmacists

Norwegian Pharmacy Association

North Carolina Association of Pharmacists

North Carolina Board of Pharmacy

Ohio Pharmacists Association

Ohio Society of Health-System Pharmacists

Ohio State Board of Pharmacy

Oklahoma Society of Health-System Pharmacists

Oklahoma State Board of Pharmacy

Ontario Pharmacists' Association

Oregon Board of Pharmacy

Oregon State Pharmacy Association

Organization of Pharmaceutical Unity with BioAllied Sciences (OPUBS)

Pan American Health Organization

Pediatric Pharmacy Advocacy Group

Pennsylvania Pharmacists Association

Pharmaceutical Education & Research Institute (PERI)

Pharmaceutical Research and Manufacturers of America (PhRMA)

Pharmaceutical Research and Manufacturers of America Foundation

Pharmaceutical Society of Australia

Pharmaceutical Society of Korea

Pharmacists Society of the State of NY

Pharmacy Benefit Management Institute, Inc.

Pharmacy Guild of Australia

Pharmacy Technician Certification Board

Pinoy Pharmacy

Regulatory Affairs Professionals Society

Rhode Island Society of Health-System Pharmacists

Royal Microscopial Society

Royal Pharmaceutical Society of Great Britain

RTC, Roundtable of Toxicology Consultants

San Diego County Pharmacists Association (SDCPhA)

SNPhA - Student National Pharmaceutical Association

Society for Biomolecular Sciences

Society of Hospital Pharmacists of Australia

Society of Pharmaceutical Education & Research [SPER]

South African Association of Hospital & Institutional Pharmacists

South Carolina Pharmacy Association

Southeastern Michigan Society of Health-System Pharmacists

Southeastern Society of Health-System Pharmacists

Tennessee Pharmacists Association

Texas State Board of Pharmacy

The Pharmaceutical Association of Mauritius

Turkish Pharmacists Association

University College of Pharmaceutical Sciences

Utah Pharmaceutical Association

World Health Organization (WHO)